Trump unveils Great Healthcare Plan to slash drug costs

President Donald Trump has dropped a major policy proposal that could reshape the healthcare landscape for millions of Americans.

On Thursday, Trump introduced the Great Healthcare Plan via a video announcement, outlining a comprehensive strategy to reduce prescription drug prices, cut health insurance premiums, enhance price transparency, and hold large insurance companies accountable, all while redirecting taxpayer-funded subsidies from insurers directly to individuals.

Breaking Down the Plan's Core Goals

Supporters contend that this plan could finally address the runaway healthcare costs that Congress has struggled to tackle for years, Breitbart reported.

Trump's proposal builds on policies his administration has already pursued, aiming to codify measures like the Most-Favored-Nation deals to secure the lowest drug prices globally for Americans.

It also pushes for more over-the-counter access to verified pharmaceuticals, a move that could save consumers time and money at the pharmacy counter.

Redirecting Funds to the People

One of the boldest elements is redirecting billions in taxpayer subsidies from health insurers straight to the American people, letting them choose plans that fit their needs.

As Trump put it, “The government is going to pay the money directly to you. It goes to you, and then you take the money and buy your own health care.” (Donald Trump)

Sure, empowering individuals sounds great, but one has to wonder if this sidesteps the bloated bureaucracy only to create a new maze of decision-making for everyday folks.

Transparency Rules to Expose Insurers

The plan doesn’t stop at funding—it demands accountability from insurers by requiring them to post profits, rejection rates, wait times, and rate comparisons for consumers.

Healthcare providers accepting Medicare or Medicaid must also display pricing openly and ensure insurers comply with transparency rules, a nod to fairness that could expose hidden costs.

Back in 2024, then-Sen. Mike Braun (R-IN) called codifying such transparency rules “bigger than Obamacare,” a hefty claim that signals just how transformative this could be. (Mike Braun)

Tackling Middlemen and Hidden Costs

Another jab at the system comes with ending kickbacks from pharmacy benefit managers to brokerage middlemen, a practice the plan argues artificially inflates insurance costs.

Add to that a cost-sharing reduction program projected to lower premiums by at least 10 percent and save taxpayers $36 billion per the Congressional Budget Office, and you’ve got a fiscal win—if the numbers hold up.

Yet, while the plan’s inclusion in the Big Beautiful Bill hit a wall with Senate Democrats citing the Byrd Rule over cost-sharing payments, it’s clear the fight for affordable care is far from over, and Trump’s latest push might just force a reckoning with a system that’s long favored corporate interests over struggling families.